|
End-of-day quote
LUXEMBOURG S.E.
2026-10-02
|
5-day change | 1st Jan Change | ||
| 38.00 USD | 0.00% |
|
-3.06% | +25.83% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,025B | |||||
| 623B | - | ||||
| 459B | |||||
| 355B | |||||
| 336B |
Select your edition
All financial news and data tailored to specific country editions
